Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 205 participants.
Also called NCT01736150
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 205 participants
- Sponsor
- Genzyme, a Sanofi Company
- Registry
-
NCT01736150
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01736150. Randomized; double masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2010-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis
- Condition
- Chronic Kidney Disease
- Condition
- Chronic Kidney Disease on Hemodialysis
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Sevelamer carbonate
- Lead sponsor
- Genzyme, a Sanofi Company
Record details
- Record id
cardio:ct-nct01736150- Content hash
d562118ecd697d22a5a916b6616d4fc493c618ea58b1285bf901574f49fec23b